InvestSMART

AtCor Medical Holdings Limited (ASX: ACG) - Announcements

- Current share price for ACG : $0.027

ASX company news and announcements for AtCor Medical Holdings Limited (ACG) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AtCor Medical Holdings Limited (ACG) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AtCor Medical Holdings Limited (ACG), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AtCor Medical Holdings Limited (ACG)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Strategic Alliance with SunTech Medical 23 Jan 2012 9:58AM $0.090 $0.027 fallen by 70%
- Three US medical associations support central BP assessment 11 Jan 2012 10:04AM $0.090 $0.027 fallen by 70%
- US$0.9 million pharmaceutical contract 2 Nov 2011 11:26AM $0.080 $0.027 fallen by 66.25%
- Appendix 4C - quarterly 21 Oct 2011 11:00AM $0.080 $0.027 fallen by 66.25%
- Positive Medicare ruling in New York State 13 Oct 2011 9:29AM $0.070 $0.027 fallen by 61.43%
- US$1.86 million new pharmaceutical contracts 10 Oct 2011 10:38AM $0.062 $0.027 fallen by 56.45%
- FY2012 revenue update 29 Aug 2011 11:28AM $0.080 $0.027 fallen by 66.25%
- Preliminary Final Report 26 Aug 2011 10:03AM $0.077 $0.027 fallen by 64.94%
- Market Update 28 Jul 2011 11:23AM $0.094 $0.027 fallen by 71.28%
- Appendix 4C - quarterly 28 Jul 2011 11:21AM $0.080 $0.027 fallen by 66.25%
- Worldwide agreement with SunTech Medical 27 Jul 2011 12:07PM $0.115 $0.027 fallen by 76.52%
- US$1.25 million new pharmaceutical contracts 1 Jul 2011 10:20AM $0.155 $0.027 fallen by 82.58%
- Appendix 4C - quarterly 28 Apr 2011 10:13AM $0.130 $0.027 fallen by 79.23%
- Sonic Healthcare`s Lifescreen to offer SphygmoCor test 5 Apr 2011 10:14AM $0.115 $0.027 fallen by 76.52%
- Breaking Study New Alternative in Aortic Pressure Monitoring 28 Mar 2011 12:30PM $0.092 $0.027 fallen by 70.65%
- US$0.6 million new pharmaceutical contract 8 Mar 2011 9:57AM $0.100 $0.027 fallen by 73%
- 15-year Taiwanese study endorses central BP measurement 4 Mar 2011 11:50AM $0.100 $0.027 fallen by 73%
- Half Yearly Report and Accounts 17 Feb 2011 3:30PM $0.130 $0.027 fallen by 79.23%
- Appendix 4C - quarterly 31 Jan 2011 8:34AM $0.100 $0.027 fallen by 73%
- US$1.28 million new pharmaceutical contract 21 Dec 2010 11:13AM $0.091 $0.027 fallen by 70.33%
- US$250,000 new research sale 20 Dec 2010 11:54AM $0.081 $0.027 fallen by 66.67%
- US$1.1 million new pharmaceutical contract 6 Dec 2010 10:16AM $0.080 $0.027 fallen by 66.25%
- US Therapeutic Project Grant 4 Nov 2010 9:38AM $0.105 $0.027 fallen by 74.29%
- Appendix 4C - First Quarter Report 27 Oct 2010 6:15PM $0.105 $0.027 fallen by 74.29%
- Rights Offer Booklet 22 Oct 2010 1:06PM $0.110 $0.027 fallen by 75.45%

201 - 225 of 300 results

Page 9 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.